Condition: Healthy · Sponsor: JW Pharmaceutical
This clinical trial is a randomized, double-blind, placebo-controlled, single ascending dose, phase 1 clinical trial to evaluate the safety/tolerability and pharmacokinetic characteristics, and to explore food effect and ethnic difference of JW2286 after oral administration in healthy adults.
This description comes directly from the study's public registry record.
Hyeona Kim · +82-840-6791 · hyeona.kim@jwhealthcare.com
Soojin Park · +82-2-840-6166 · park.soojin@jwhealthcare.com
Always discuss trial participation with your own doctor first.
| Seoul National University Hospital Clinical Trial Center | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06703710